Characteristics of patients with MSI-H pancreatic cancer
| Characteristic | n=10 |
| Age at diagnosis, median (range), years | 68 (65–82) |
| Sex | |
| Male | 8 (80%) |
| Female | 2 (20%) |
| Race | |
| Caucasian | 10 (100%) |
| Site of the primary tumor | |
| Head | 4 (40%) |
| Body | 3 (30%) |
| Tail | 2 (20%) |
| Stage at diagnosis | |
| Metastatic | 8 (80%) |
| Locally advanced | 2 (20%) |
| Line in which immunotherapy received | |
| First line | 3 (30%) |
| Second line | 3 (30%) |
| Third line | 3 (30%) |
| Not received | 1 (10%) |
| Prior therapy | 6 (60%) |
MSI-H, microsatellite instability-high.